Hebert Dichtelmuller

Title: Hebert Dichtelmuller: Innovator in Immunoglobulin Preparation

Introduction

Hebert Dichtelmuller is a notable inventor recognized for his contributions to the field of immunology. He is based in Sulzbach/Ts., Germany, and has made significant advancements in the development of polyclonal immunoglobulin preparations. His work focuses on creating effective treatments for bacterial infections.

Latest Patents

Dichtelmuller holds a patent for an "Intravenously administrable polyclonal immunoglobulin preparation." This innovative preparation is designed for the treatment and prophylaxis of bacterial infections. It contains at least 50% by weight of IgM in terms of the total content of immunoglobulin. The preparation exhibits low anticomplementary activity, is stable in aqueous solution, and is free of viruses. Additionally, it can consist of or contain a mixture of several monoclonal IgM antibodies. The source material for its manufacture is an immunoglobulin-containing fraction derived from human, animal, or bacterial origins. The fraction undergoes treatment with an anion exchanger and may be subjected to gel filtration, along with other processing methods to ensure its efficacy and safety.

Career Highlights

Dichtelmuller is associated with Biotest Pharma GmbH, where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and application of immunoglobulin therapies.

Collaborations

Hebert Dichtelmuller has collaborated with notable colleagues, including Wolfgang Moller and Norbert Kothe. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of immunology.

Conclusion

Hebert Dichtelmuller is a distinguished inventor whose work in immunoglobulin preparation has the potential to significantly impact the treatment of bacterial infections. His innovative approaches and collaborations continue to drive advancements in medical science.